Identification of a small set of plasma signalling proteins using neural network for prediction of Alzheimer's disease

Bioinformatics

Volumn 31, Issue 15, 2015, Pages 2505-2513

  Agarwal, Swapna ^a   Ghanty, Pradip ^b   Pal, Nikhil R ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

^b Praxis Softek Solutions Pvt Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN;

ALZHEIMER DISEASE; ARTIFICIAL NEURAL NETWORK; BLOOD; BRAIN; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; METABOLISM; MILD COGNITIVE IMPAIRMENT; PRINCIPAL COMPONENT ANALYSIS;

ALZHEIMER DISEASE; BIOMARKERS; BLOOD PROTEINS; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MILD COGNITIVE IMPAIRMENT; NEURAL NETWORKS (COMPUTER); PRINCIPAL COMPONENT ANALYSIS;

EID: 84943623488     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btv173     Document Type: Article

References (30)

1. Basak, J. and Mitra, S. (1999) Feature selection using radial basis function networks. Neural Comput. Appl., 8, 297-302.
2. Beilharz, E. J. et al. (1993) Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Mol. Brain Res., 18, 209-215.
3. Bermejo, P. F. et al. (2008) Incidence and subtypes of dementia in three elderly populations of central Spain. J. Neurol. Sci., 264, 63-72.
4. Carlo, D. et al. (2002) Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J. Am. Geriatr. Soc., 50, 41-48.
5. Craig-Schapiro, R. et al. (2011) Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and drognosis, PLoS ONE, 6, e18850.
6. Chakraborty, D. and Pal, N. R. (2008) Selecting useful groups of features in a connectionist framework. IEEE Trans. Neural Networks, 19, 381-396.
7. Eriksson, U. (2013) Targeting VEGF-b regulation of fatty acid transporters to modulate human diseases. US Patent 8, 383, 112.
8. German, D. C. et al. (2007) Serum biomarkers for Alzheimer's disease: prot discovery. Biomed. Pharmacother., 61, 383-389.
9. Guyon, I. et al. (2002) Gene selection for cancer classification using support vector machines. Mach. Learn., 46, 389-422.
10. Hansson, O. et al. (2006) Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol., 53, 228-234.
11. Hernandez, F. and Avila, J. (2007) Taopathies. Cell. Mol. Life Sci., 64, 2219-2233.
12. Hooper, N. M. et al. (2005) Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem. Soc. Trans., 33, 335-338.
13. Hu, W. T. et al. (2010) Novel CSF biomarkers for Alzheimers disease and mild cognitive impairment. Acta Neuropatholica, 119, 669-678.
14. Hye, A. et al. (2006) Proteome-based plasma biomarkers for Alzheimer's disease. Brain, 129, 3042-3050.
15. Kira, K., Rendell, L. A. (1992) The feature selection problem: traditional methods and a new algorithm. AAAI, 2, 129-134.
16. Kohavi, R., John, G., (1997) Wrappers for feature subset selection. Artif. Intell., 97, 273-324.
17. Kononenko, I. et al. (1997) Overcoming the myopia of inductive learning algorithms with RELIEFF. Appl. Intell., 7, 39-55.
18. Lee, M. H. et al. (2010) TGF-b induces TIAF1 self-aggregation via type II receptor-independent signaling that leads to generation of amyloid b plaques in Alzheimer's disease. Cell Death Dis., 1, e110.
19. Pal, N. R. and Malpani, M. (2012) Redundancy-constrained feature selection with radial basis function networks. In: Proceedings of the WCCI 2012 IEEE World Congress on Computational Intelligence, June 10-15, 2012. Brisbane, Australia, doi:10.1109/IJCNN.2012.6252638.
20. Peress, N. S. and Perillo, E. (1995) Differential expression of TGF-beta 1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J. Neuropathol. Exp. Neurol., 54, 802-811.
21. Ray, S. et al. (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med., 13, 1359-1362.
22. Rentzos, M. et al. (2006) Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. J. Neurol. Sci., 249, 110-114.
23. Sun, S. et al. (2014) A kernel-based multivariate feature selection method for microarray data classification. PLoS ONE, 9, e102541.
24. Teramoto, R. (2008) Prediction of Alzheimer's diagnosis using semi-supervised distance metric learning with label propagation. Comput. Biol. Chem., 32, 438-441.
25. Tham, A. et al. (1993) Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J. Neural Transm. Park. Dis. Dement. Sect., 5, 165-176.
26. Tiraboschi, P. et al. (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology, 62, 1984-1989.
27. Tobinick, E. L. and Gross, H. (2008) Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J. Neuroinflammation, 5, 2, doi:10.1186/1742-2094-5-2.
28. Town, T. et al. (2008) Blocking TGF-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med., 14, 681-687.
29. Westin, K. et al. (2012) CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease. PLoS ONE, 7, e30525.
30. Xiao, Z. et al. (2005) Proteomic patterns: their potential for disease diagnosis. Mol. Cell. Endocrinol., 230, 96-106.